Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are the two most common skin cancers, accounting for more than 5 million diagnoses in the U.S. each year. Both arise from sun-damaged skin cells, but they differ significantly in growth behavior, metastatic potential, and treatment approach. Understanding these differences helps patients make informed decisions about their care.
Side-by-Side Comparison
| Feature | Basal Cell Carcinoma (BCC) | Squamous Cell Carcinoma (SCC) |
|---|---|---|
| Cell of origin | Basal cells (deepest epidermal layer) | Squamous cells (outer epidermal layer) |
| Incidence | ~3.6 million cases/yr (U.S.) | ~1.8 million cases/yr (U.S.) |
| Typical appearance | Pearly or translucent nodule; rolled border; may ulcerate | Firm red nodule or flat lesion; scaly or crusted surface |
| Growth rate | Slow | Faster; more aggressive |
| Metastasis risk | Very low (<0.1%) | 2–5% overall; higher for high-risk subtypes |
| Common locations | Face, head, neck (80%) | Sun-exposed areas; also lip, ear, mucous membranes |
| Primary risk factor | Cumulative UV exposure | UV exposure, chronic wounds, immunosuppression |
| Preferred treatment (high-risk sites) | Mohs micrographic surgery | Mohs micrographic surgery |
| 5-year cure rate (Mohs) | Up to 99% (primary) | Up to 97% (primary) |
Basal Cell Carcinoma: What You Need to Know
BCC is the most common human cancer. It arises from basal cells — the stem cells that line the deepest layer of the epidermis — most often on chronically sun-exposed skin. Despite being the most prevalent, it is also the most predictable: BCC grows slowly, remains localized in the vast majority of cases, and is highly curable when treated appropriately.
Subtypes and their significance
- Nodular BCC — the most common subtype; a pearly, skin-colored or pink nodule with fine telangiectasias (blood vessels) on the surface. Well-defined borders make it amenable to standard excision in many locations.
- Superficial BCC — a flat, erythematous plaque, more common on the trunk. May be treated with topical agents or photodynamic therapy in low-risk settings.
- Morpheaform / infiltrative / micronodular BCC — aggressive subtypes with indistinct clinical borders that extend beyond what is visible. These require Mohs surgery to fully excise — standard excision significantly underestimates the true tumor extent.
Why BCC on the eyelid is particularly challenging: BCC accounts for 85–95% of malignant eyelid tumors. Periocular BCC often presents as a subtle area of lash loss or a barely-perceptible nodule — and because eyelid anatomy is critical for corneal protection and tear drainage, reconstruction requires an oculoplastic specialist. Belaray Dermatology is the only Tri-State practice with both Mohs surgery and oculoplastic reconstruction under one roof.
Squamous Cell Carcinoma: What You Need to Know
SCC arises from squamous cells in the outer layers of the skin. It is more common in patients with fair skin, significant cumulative UV exposure, a history of precancerous lesions (actinic keratoses), organ transplantation, or other immunosuppression. Unlike BCC, SCC carries a meaningful risk of regional spread and requires prompt treatment.
High-risk features that indicate Mohs surgery
- Location on the face (especially lip, ear, periocular area), scalp, or genitals
- Diameter >2 cm
- Depth >2 mm or invasion into subcutaneous fat
- Perineural or perivascular invasion on pathology
- Poorly differentiated or undifferentiated histology
- Arising in a scar, chronic wound, or site of prior radiation
- Immunocompromised patient (transplant, HIV, chronic immunosuppression)
- Recurrent tumor
Actinic keratoses: the precursor to SCC
Actinic keratoses (AKs) are rough, scaly patches caused by years of UV exposure. They are not yet skin cancer — but they are the most common precursor to SCC, with an estimated 5–10% of untreated AKs progressing to invasive SCC over a lifetime. Regular dermatology visits allow AKs to be treated before they advance.
Frequently Asked Questions
What is the difference between basal cell carcinoma and squamous cell carcinoma?
BCC arises from basal cells in the deepest epidermal layer, grows slowly, and rarely spreads to other parts of the body. SCC arises from squamous cells in the outer skin layer, grows more aggressively, and carries a meaningful risk of regional lymph node spread — particularly for high-risk subtypes and immunocompromised patients.
Is squamous cell carcinoma more dangerous than basal cell carcinoma?
Generally yes. While both are highly treatable when detected early, SCC carries a higher metastatic risk (~2–5% overall, higher for high-risk tumors). BCC rarely metastasizes but can be locally destructive if untreated, especially around the eye, ear, or nose.
Does basal cell carcinoma require Mohs surgery?
Mohs surgery is preferred for BCC on the face, head, neck, hands, feet, and genitals; for recurrent tumors; and for aggressive subtypes (morpheaform, infiltrative, micronodular). For low-risk BCC on the trunk or extremities, standard excision or curettage and electrodesiccation may be appropriate alternatives.
Suspicious Spot? Schedule a Skin Cancer Evaluation
Belaray Dermatology's three dual board-certified Mohs surgeons evaluate and treat BCC and SCC at offices in Hicksville and Stony Brook, Long Island. Most insurance plans accepted.